TY - JOUR
T1 - μ, but not κ, opioid agonists induce contractions of the canine small intestine ex vivo
AU - Hirning, Lane D.
AU - Porreca, Frank
AU - Burks, Thomas F.
N1 - Funding Information:
This work was supported by USPHS Grant DA02163 from NIDA, and a Merck Postdoctoral Fellowship to Dr. Porreca. We gratefully acknowledge the generous gifts of compounds used in this study by the following companies: Endo; Merck, Sharp and Dohme; Sandoz; Smith, Kline and French; and Upjohn. The authors wish to thank Mrs. Cathy Braun for the final preparation of this manuscript.
PY - 1985/2/12
Y1 - 1985/2/12
N2 - The proposed κ opioid receptor agonists ethylketocyclazocine (EK), nalorphine, bremazocine and U-50,488H were evaluated for their ability to produce contractions of isolated, vascularly perfused canine small intestinal segments. Responses to these agonists were compared to those of morphine and phenazocine, a μ benzomorphan. Morphine (0.04-25 μg) and phenazocine (0.01-3.0 μg) both produced naloxone-reversible contractions, suggesting that the responses were mediated largely by μ opioid receptors. In contrast, the proposed κ agonists were ineffective in producing intestinal stimulation, with only EK (1-100 μg) showing minimal but significant activity at very high doses. We suggest that the effects of EK may be mediated through μ opioid receptors and that κ receptors appear not to be involved in the contractile response of the dog small intestine to opioids.
AB - The proposed κ opioid receptor agonists ethylketocyclazocine (EK), nalorphine, bremazocine and U-50,488H were evaluated for their ability to produce contractions of isolated, vascularly perfused canine small intestinal segments. Responses to these agonists were compared to those of morphine and phenazocine, a μ benzomorphan. Morphine (0.04-25 μg) and phenazocine (0.01-3.0 μg) both produced naloxone-reversible contractions, suggesting that the responses were mediated largely by μ opioid receptors. In contrast, the proposed κ agonists were ineffective in producing intestinal stimulation, with only EK (1-100 μg) showing minimal but significant activity at very high doses. We suggest that the effects of EK may be mediated through μ opioid receptors and that κ receptors appear not to be involved in the contractile response of the dog small intestine to opioids.
KW - Bremazocine
KW - Dog
KW - Ethylketocyclazocine
KW - Small intestinal motility
KW - U-50,488H
KW - κ opioid receptors
UR - http://www.scopus.com/inward/record.url?scp=0021996455&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021996455&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(85)90538-2
DO - 10.1016/0014-2999(85)90538-2
M3 - Article
C2 - 2986990
AN - SCOPUS:0021996455
VL - 109
SP - 49
EP - 54
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
SN - 0014-2999
IS - 1
ER -